Clinical Trial Update: Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on liraglutide in young adults with type 2 diabetes and cardiovascular disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: University of Leicester | Conditions: Type 2 Diabetes Mellitus, Cardiovascular Disease | Phase 3 | Status: COMPLETED